Scimago Journal & Country Rank
menu
| Title | Type | SJR |  H index |
Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Cancer | journal | 19.575 Q1 | 505 | 88 | 370 | 8894 | 9218 | 202 | 18.59 | 101.07 |  |
| 2 | Journal of the National Cancer Institute | journal | 5.797 Q1 | 387 | 177 | 679 | 5160 | 5180 | 455 | 7.87 | 29.15 | |
| 3 | Oncogene | journal | 3.395 Q1 | 370 | 492 | 1599 | 26581 | 13800 | 1587 | 8.45 | 54.03 | |
| 4 | British Journal of Cancer | journal | 2.833 Q1 | 272 | 443 | 1155 | 18731 | 7285 | 1050 | 5.90 | 42.28 | |
| 5 | European Journal of Cancer | journal | 3.354 Q1 | 245 | 416 | 1157 | 12341 | 8259 | 961 | 6.70 | 29.67 | |
| 6 | Carcinogenesis | journal | 1.688 Q2 | 223 | 172 | 452 | 8072 | 2149 | 437 | 4.07 | 46.93 | |
| 7 | Leukemia | journal | 4.539 Q1 | 219 | 386 | 1035 | 12827 | 8108 | 792 | 8.24 | 33.23 | |
| 8 | Molecular Cancer | journal | 7.274 Q1 | 196 | 155 | 492 | 13169 | 11747 | 459 | 25.22 | 84.96 | |
| 9 | Breast Cancer Research | journal | 2.378 Q1 | 175 | 129 | 428 | 5685 | 2593 | 423 | 5.63 | 44.07 | |
| 10 | Cell Death and Disease | journal | 2.482 Q1 | 164 | 1024 | 2663 | 50416 | 20547 | 2589 | 7.52 | 49.23 | |
| 11 | Neuro-Oncology | journal | 4.005 Q1 | 163 | 244 | 606 | 7226 | 4855 | 448 | 6.68 | 29.61 | |
| 12 | BMC Cancer | journal | 1.358 Q2 | 160 | 1203 | 3415 | 45082 | 14270 | 3411 | 4.14 | 37.47 | |
| 13 | Endocrine-Related Cancer | journal | 1.892 Q1 | 146 | 102 | 383 | 6194 | 2004 | 351 | 4.93 | 60.73 | |
| 14 | Journal of Hematology and Oncology | journal | 4.305 Q1 | 144 | 163 | 440 | 14177 | 5901 | 436 | 14.91 | 86.98 | |
| 15 | Oral Oncology | journal | 1.623 Q2 | 137 | 445 | 901 | 13388 | 3676 | 728 | 3.79 | 30.09 | |
| 16 | Journal of Experimental and Clinical Cancer Research | journal | 2.752 Q1 | 120 | 252 | 904 | 14857 | 8592 | 904 | 9.79 | 58.96 | |
| 17 | Journal for ImmunoTherapy of Cancer | journal | 5.060 Q1 | 117 | 508 | 582 | 19284 | 7039 | 571 | 11.60 | 37.96 | |
| 18 | Signal Transduction and Targeted Therapy | journal | 4.284 Q1 | 117 | 291 | 130 | 21482 | 2163 | 109 | 13.12 | 73.82 | |
| 19 | Leukemia and Lymphoma | journal | 0.961 Q3 | 102 | 516 | 1433 | 14463 | 2619 | 848 | 1.78 | 28.03 | |
| 20 | Cancer Gene Therapy | journal | 1.535 Q2 | 99 | 91 | 128 | 3977 | 668 | 125 | 4.81 | 43.70 | |
| 21 | International Journal of Hyperthermia | journal | 0.896 Q3 | 98 | 183 | 545 | 8394 | 2066 | 515 | 3.56 | 45.87 | |
| 22 | Leukemia Research | journal | 0.853 Q3 | 96 | 116 | 537 | 3223 | 1185 | 445 | 2.13 | 27.78 | |
| 23 | Japanese Journal of Clinical Oncology | journal | 0.768 Q3 | 95 | 161 | 587 | 4519 | 1287 | 537 | 2.21 | 28.07 | |
| 24 | Journal of Oral Pathology and Medicine | journal | 0.887 Q3 | 95 | 142 | 432 | 4379 | 1450 | 406 | 3.78 | 30.84 | |
| 25 | Future Oncology | journal | 0.857 Q3 | 90 | 294 | 1048 | 13111 | 2676 | 965 | 2.69 | 44.60 | |
| 26 | Cancer Medicine | journal | 1.403 Q2 | 84 | 863 | 1598 | 33084 | 6927 | 1594 | 4.09 | 38.34 | |
| 27 | Cancer Cell International | journal | 1.322 Q2 | 80 | 565 | 665 | 25161 | 3384 | 665 | 5.19 | 44.53 | |
| 28 | Cancer Communications | journal | 2.119 Q1 | 79 | 74 | 210 | 2813 | 1408 | 171 | 7.43 | 38.01 | |
| 29 | Prostate Cancer and Prostatic Diseases | journal | 2.000 Q1 | 78 | 89 | 217 | 2821 | 990 | 204 | 4.42 | 31.70 | |
| 30 | Epigenomics | journal | 1.265 Q2 | 77 | 154 | 371 | 9073 | 1501 | 349 | 3.96 | 58.92 | |
| 31 | Advances in Biological Regulation | journal | 2.130 Q1 | 69 | 45 | 137 | 3832 | 781 | 129 | 5.40 | 85.16 | |
| 32 | ESMO Open | journal | 2.409 Q1 | 60 | 225 | 300 | 7177 | 1446 | 234 | 4.65 | 31.90 | |
| 33 | Cell Death Discovery | journal | 1.556 Q2 | 58 | 133 | 312 | 7153 | 1531 | 297 | 4.65 | 53.78 | |
| 34 | Hematological Oncology | journal | 0.918 Q3 | 54 | 107 | 393 | 3891 | 1002 | 324 | 2.72 | 36.36 | |
| 35 | ecancermedicalscience | journal | 0.708 Q3 | 47 | 175 | 301 | 6657 | 735 | 298 | 2.18 | 38.04 | |
| 36 | Infectious Agents and Cancer | journal | 0.774 Q3 | 47 | 70 | 146 | 3035 | 417 | 146 | 2.70 | 43.36 | |
| 37 | Experimental Hematology and Oncology | journal | 1.223 Q2 | 42 | 37 | 96 | 2219 | 372 | 95 | 4.33 | 59.97 | |
| 38 | Molecular Therapy - Oncolytics | journal | 1.424 Q2 | 42 | 153 | 149 | 7492 | 854 | 149 | 6.22 | 48.97 | |
| 39 | Molecular and Cellular Oncology | journal | 0.696 Q3 | 37 | 123 | 310 | 1475 | 407 | 264 | 1.28 | 11.99 | |
| 40 | npj Precision Oncology | journal | 36 | 33 | 61 | 2009 | 450 | 60 | 7.32 | 60.88 | | |
| 41 | European Journal of Cancer, Supplement | journal | 29 | 11 | 0 | 804 | 0 | 0 | 0.00 | 73.09 | | |
| 42 | Cancer Treatment and Research Communications | journal | 0.459 Q4 | 23 | 98 | 92 | 3570 | 136 | 89 | 1.59 | 36.43 | |
| 43 | Molecular and Clinical Oncology | journal | 0.442 Q4 | 19 | 229 | 116 | 6220 | 194 | 116 | 1.67 | 27.16 | |
| 44 | Cancer Reports | journal | 0.261 Q4 | 18 | 66 | 82 | 2701 | 63 | 78 | 0.77 | 40.92 | |
| 45 | FASEB BioAdvances | journal | 18 | 60 | 58 | 3058 | 84 | 56 | 1.45 | 50.97 | | |
| 46 | NAR Cancer | journal | 17 | 36 | 1 | 2962 | 0 | 0 | 0.00 | 82.28 | | |
| 47 | Function | journal | 16 | 23 | 0 | 993 | 0 | 0 | 0.00 | 43.17 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data